Best in Biotech 16 Apr 2024
Seven biotech companies climbing their way up in Colorado
We take a look at seven biotechs in Colorado that have secured funding in recent years, to make headway with their pipeline candidates.
About
Having completed a master’s programme in International Journalism from Cardiff University in 2022, I have written about various subjects including culture, politics, social justice, mental health, LGBTQ+ issues and gender. My undergraduate degree in life sciences has equipped me to explore my passion for reporting on health, science and the environment. When I’m not transcribing interviews and fretting about deadlines, I like to spend my time reading, watching movies, and making lousy mixtapes for a potential side career in rap music.
Articles by Roohi Mariam Peter
In Depth 15 Apr 2024
Does the FDA need to tighten its grip on drug trials in the U.S.?
Studies suggest that the FDA has been less rigorous with its drug approval standards. We looked at the current state of the approval process.
Best in Biotech 11 Apr 2024
Seven companies leading the mRNA revolution in biotechnology
Here are seven mRNA biotechs that have raised funds in recent years to push their candidates ahead through preclinical and clinical trials.
Best in Biotech 9 Apr 2024
Eight biotech companies you should know about in Austria
Here are eight Austrian biotech companies that have received funding in recent years to propel their pioneering innovations forward.
Best in Biotech 28 Mar 2024
Are these T cell receptor (TCR) therapy companies on your radar?
As biotechs step up in the TCR therapy space, here are seven companies with promising candidates in the clinic.
In Depth 27 Mar 2024
Are new treatments for multiple sclerosis on the horizon?
As the wait for new multiple sclerosis treatments continue, here are some ongoing clinical trials that hold promise.
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 21 Mar 2024
Eight CAR-T cell therapy companies you should know about
Discover eight promising biotech companies that are advancing their CAR T cell therapy candidates in the clinic.
In Depth 20 Mar 2024
Are molecular glues the key to undruggable targets?
As more biopharmas get sticky with molecular glue developers and venture capital interest grows, here is a review of the field.
In Depth 14 Mar 2024
Rett syndrome: advances in gene therapy brings hope
Explore the latest advancements in treating Rett syndrome, a rare genetic disorder, including groundbreaking gene therapies and drug trials.
In Depth 11 Mar 2024
Biotech bankruptcies: what to expect in 2024 following a record year?
2023 broke the record for the highest number of biotech bankruptcies in a decade. Can biotechs mitigate the risk in 2024?
In Depth 7 Mar 2024
Can AbbVie’s legacy live beyond its once best-selling drug Humira?
The sales of AbbVie’s Humira, once a best-seller, have dropped. Now, with a new CEO announced, things are about to change for the company.
Expert Advice 1 Mar 2024
Tips on how to write a compelling biotech resume
Discover expert advice from recruiters on crafting a standout biotech resume that grabs employers’ attention and lands you interviews.
ADVERTISEMENT
